乳腺癌伴随疾病全方位管理之内分泌代谢性疾病管理
|
摘要
乳腺癌伴随疾病与内分泌代谢疾病密不可分,内分泌代谢疾病在乳腺癌的发生、发展、治疗与预后中起着重要的作用。在乳腺癌的治疗过程中尚需规范乳腺癌患者伴随的内分泌代谢疾病的预防与管理,以进一步提高乳腺癌患者的生活质量和改善预后。
Concomitant diseases of breast cancer are closely related to the endocrine and metabolic diseases,which is associated with the occurrence,development treatment and prognosis of breast cancer,but that is far from adequate attention. Therefore,we should pay more attention to prevention and treatment of the endocrine and metabolic diseases to improve the quality of life and prognosis of the breast cancer patients.
Concomitant diseases of breast cancer are closely related to the endocrine and metabolic diseases,which is associated with the occurrence,development treatment and prognosis of breast cancer,but that is far from adequate attention. Therefore,we should pay more attention to prevention and treatment of the endocrine and metabolic diseases to improve the quality of life and prognosis of the breast cancer patients.
引文
1孔令泉,李浩,厉红元,等.关注乳腺癌伴随疾病的诊治[J].中华内分泌外科杂志,2018,12(5):353-357.
2孔令泉,吴凯南,果磊,主编.乳腺癌伴随疾病学[M].北京:科学出版社,2019:1-9.
3孔令泉,李欣,厉红元,等.关注乳腺癌患者血脂异常的诊断与防治[J].中华内分泌外科杂志,2017,11(2):89-91,96.
4孔令泉,吴凯南,厉红元,主编.乳腺肿瘤心脏病学[M].北京:科学出版社,2018:136-146.
5李浩,孔令泉,吴凯南.乳腺肿瘤心脏病学的建立及多学科协作的意义[J].中国临床新医学,2018,11(1):94-97.
6 Patnaik JL,Byers T,Di Guiseppi C,et al.Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer:a retrospective cohort study[J].Breast Cancer Res,2011,13(3):R64.
7 Li X,Liu ZL,Wu YT,et al.Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy[J].Lipids Health Dis,2018,17(1):91.
8中国乳腺癌内分泌治疗多学科管理血脂异常管理共识专家组.绝经后早期乳腺癌患者血脂异常管理的中国专家共识[J].中华肿瘤杂志,2017,39(1):72-77.
9孔令泉,吴凯南,主编.乳腺肿瘤糖尿病学[M].重庆:重庆出版社,2014:1-13.
10孔令泉,卢林捷,吴凯南.关注乳腺癌患者中糖尿病的筛查诊断[J].中华内分泌外科杂志,2015,9(3):180-184.
11李浩,孔令泉,吴凯南.关注乳腺癌患者的糖耐量减低[N].中国医学论坛报,2018-10-25 B8版.
12 Lu LJ,Wang RJ,Ran L,et al.On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test[J].PLo S One,2014,9(4):e93630.
13 Ji GY,Jin LB,Wang RJ,et al.Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment[J].Med Oncol,2013,30(3):687.
14 Lu LJ,Gan L,Hu JB,et al.On the status ofβ-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment[J].Med Oncol,2014,31(5):956.
15 Qiuhong Gong,Jixiang Ma,Ping Zhang,et al.Lifestyle intervention reduces the CVD of people with IGT during the 30-year follow-up of Daqing Diabetes Prevention study in China[R].ADA,2018,78th Scientific Sessions.
16卢林捷,王瑞珏,孔令泉,等.首诊乳腺癌筛查发现未知晓糖尿病一例[J].中华内分泌外科杂志,2014,8(2):137.
17王瑞珏,卢林捷,孔令泉,等.乳腺癌化疗诱发糖尿病一例[J].中华内分泌外科杂志,2014,8(2):140.
18罗清清,卢林捷,孔令泉,等.乳腺癌化疗期间糖耐量异常转为正常二例[J].中华内分泌外科杂志,2015,9(2):170-171.
19卢林捷,王瑞珏,孔令泉,等.无糖尿病病史的乳腺癌患者系统治疗后糖耐量异常状况研究[J].中国肿瘤临床,2014,41(4):250-253.
20卢林捷,王瑞珏,孔令泉,等.系统治疗后乳腺癌合并糖尿病二例[J].中华内分泌外科杂志,2014,8(3):256-257.
21孔令泉,吴凯南,厉红元,主编.乳腺肿瘤肝病学[M].北京:科学出版社,2017:91-104.
22吴玉团,孔令泉,厉红元,等.乳腺癌患者化疗性脂肪肝和乙肝病毒再激活的防治[J].中华内分泌外科杂志,2017,11(5):426-429.
23吴玉团,罗清清,孔令泉,等.代谢综合征与乳腺癌的关系[J].现代肿瘤医学,2016,24(22):3673-3677.
24罗清清,孔令泉.乳腺癌患者中代谢综合征发病状况的临床初步研究[D].重庆:重庆医科大学,2016.
25 Alberti KG,Eckel RH,Grundy SM,et al.Harmonizing the metabolic syndrome[J].Circulation,2009,120(16):1640-1645.
26 Wu YT,Luo QQ,Li X,et al.Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population[J].JCancer,2018,9(3):548-555.
27高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J].中华内科杂志,2017,56(3):235-248.
28孔令泉,赵春霞,厉红元,等.关注乳腺癌患者甲状腺疾病的筛查与诊治[J].中华内分泌外科杂志,2017,11(1):4-7.
29孔令泉,吴凯南,厉红元,主编.乳腺肿瘤甲状腺病学[M].北京:科学出版社,2017:1-9.
30赵春霞,孔令泉.乳腺癌患者首次确诊、化疗期间及系统治疗后甲状腺结节及甲状腺功能状况研究[D].重庆:重庆医科大学,2017.
31 Shi Y,Li X,Ran L,et al.Study on the status of thyroid function and thyroid nodules in Chinese breast cancer patients[J].Oncotarget,2017,8(46):80820-80825.
32黄剑波,汲广岩,刑雷,等.合并原发性甲亢的乳腺癌患者围术期及化疗期间甲状腺危象的防治[J].重庆医学,2012,41(27):2873-2874.
33黄剑波,邢雷,汲广岩,等.合并甲亢的乳腺癌患者微创术后发生甲状腺危象及化疗后甲低1例分析[J].重庆医科大学学报,2012,37(4):379-380.
2孔令泉,吴凯南,果磊,主编.乳腺癌伴随疾病学[M].北京:科学出版社,2019:1-9.
3孔令泉,李欣,厉红元,等.关注乳腺癌患者血脂异常的诊断与防治[J].中华内分泌外科杂志,2017,11(2):89-91,96.
4孔令泉,吴凯南,厉红元,主编.乳腺肿瘤心脏病学[M].北京:科学出版社,2018:136-146.
5李浩,孔令泉,吴凯南.乳腺肿瘤心脏病学的建立及多学科协作的意义[J].中国临床新医学,2018,11(1):94-97.
6 Patnaik JL,Byers T,Di Guiseppi C,et al.Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer:a retrospective cohort study[J].Breast Cancer Res,2011,13(3):R64.
7 Li X,Liu ZL,Wu YT,et al.Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy[J].Lipids Health Dis,2018,17(1):91.
8中国乳腺癌内分泌治疗多学科管理血脂异常管理共识专家组.绝经后早期乳腺癌患者血脂异常管理的中国专家共识[J].中华肿瘤杂志,2017,39(1):72-77.
9孔令泉,吴凯南,主编.乳腺肿瘤糖尿病学[M].重庆:重庆出版社,2014:1-13.
10孔令泉,卢林捷,吴凯南.关注乳腺癌患者中糖尿病的筛查诊断[J].中华内分泌外科杂志,2015,9(3):180-184.
11李浩,孔令泉,吴凯南.关注乳腺癌患者的糖耐量减低[N].中国医学论坛报,2018-10-25 B8版.
12 Lu LJ,Wang RJ,Ran L,et al.On the status and comparison of glucose intolerance in female breast cancer patients at initial diagnosis and during chemotherapy through an oral glucose tolerance test[J].PLo S One,2014,9(4):e93630.
13 Ji GY,Jin LB,Wang RJ,et al.Incidences of diabetes and prediabetes among female adult breast cancer patients after systemic treatment[J].Med Oncol,2013,30(3):687.
14 Lu LJ,Gan L,Hu JB,et al.On the status ofβ-cell dysfunction and insulin resistance of breast cancer patient without history of diabetes after systemic treatment[J].Med Oncol,2014,31(5):956.
15 Qiuhong Gong,Jixiang Ma,Ping Zhang,et al.Lifestyle intervention reduces the CVD of people with IGT during the 30-year follow-up of Daqing Diabetes Prevention study in China[R].ADA,2018,78th Scientific Sessions.
16卢林捷,王瑞珏,孔令泉,等.首诊乳腺癌筛查发现未知晓糖尿病一例[J].中华内分泌外科杂志,2014,8(2):137.
17王瑞珏,卢林捷,孔令泉,等.乳腺癌化疗诱发糖尿病一例[J].中华内分泌外科杂志,2014,8(2):140.
18罗清清,卢林捷,孔令泉,等.乳腺癌化疗期间糖耐量异常转为正常二例[J].中华内分泌外科杂志,2015,9(2):170-171.
19卢林捷,王瑞珏,孔令泉,等.无糖尿病病史的乳腺癌患者系统治疗后糖耐量异常状况研究[J].中国肿瘤临床,2014,41(4):250-253.
20卢林捷,王瑞珏,孔令泉,等.系统治疗后乳腺癌合并糖尿病二例[J].中华内分泌外科杂志,2014,8(3):256-257.
21孔令泉,吴凯南,厉红元,主编.乳腺肿瘤肝病学[M].北京:科学出版社,2017:91-104.
22吴玉团,孔令泉,厉红元,等.乳腺癌患者化疗性脂肪肝和乙肝病毒再激活的防治[J].中华内分泌外科杂志,2017,11(5):426-429.
23吴玉团,罗清清,孔令泉,等.代谢综合征与乳腺癌的关系[J].现代肿瘤医学,2016,24(22):3673-3677.
24罗清清,孔令泉.乳腺癌患者中代谢综合征发病状况的临床初步研究[D].重庆:重庆医科大学,2016.
25 Alberti KG,Eckel RH,Grundy SM,et al.Harmonizing the metabolic syndrome[J].Circulation,2009,120(16):1640-1645.
26 Wu YT,Luo QQ,Li X,et al.Clinical study on the prevalence and comparative analysis of metabolic syndrome and its components among Chinese breast cancer women and control population[J].JCancer,2018,9(3):548-555.
27高尿酸血症相关疾病诊疗多学科共识专家组.中国高尿酸血症相关疾病诊疗多学科专家共识[J].中华内科杂志,2017,56(3):235-248.
28孔令泉,赵春霞,厉红元,等.关注乳腺癌患者甲状腺疾病的筛查与诊治[J].中华内分泌外科杂志,2017,11(1):4-7.
29孔令泉,吴凯南,厉红元,主编.乳腺肿瘤甲状腺病学[M].北京:科学出版社,2017:1-9.
30赵春霞,孔令泉.乳腺癌患者首次确诊、化疗期间及系统治疗后甲状腺结节及甲状腺功能状况研究[D].重庆:重庆医科大学,2017.
31 Shi Y,Li X,Ran L,et al.Study on the status of thyroid function and thyroid nodules in Chinese breast cancer patients[J].Oncotarget,2017,8(46):80820-80825.
32黄剑波,汲广岩,刑雷,等.合并原发性甲亢的乳腺癌患者围术期及化疗期间甲状腺危象的防治[J].重庆医学,2012,41(27):2873-2874.
33黄剑波,邢雷,汲广岩,等.合并甲亢的乳腺癌患者微创术后发生甲状腺危象及化疗后甲低1例分析[J].重庆医科大学学报,2012,37(4):379-380.